Bevacizumab in Treating Young Patients With Refractory Solid Tumors

Clinical trial NCT00085111 · COMPLETED

Trial details

NCT number: NCT00085111
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2003-12-01
Primary completion: 2005-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.